Population
|
Seropositivity
|
Total
|
Prevalence of low ab-avidity (%)
|
Crude OR (95% CI)
|
---|
Finland (n = 248)
|
HPV16 only
|
113
|
19 (7.7%)
|
1
|
|
HPV16 + 6 or 11
|
36
|
8 (6.3%)
|
1.4 (0.6-3.6)
|
|
HPV16 + 31 or 33
|
59
|
5 (2.5%)
|
0.5 (0.2-1.3)
|
|
HPV16 + 18 or 45
|
40
|
6 (2.2%)
|
0.9 (0.3-2.4)
|
Uganda (n = 117)
|
HPV16 only
|
45
|
9 (7.7%)
|
1
|
|
HPV16 + 6 or 11
|
32
|
15 (12.8%)
|
3.5 (1.3-9.7)
|
|
HPV16 + 31 or 33
|
24
|
4 (3.4%)
|
0.8 (0.2-2.9)
|
|
HPV16 + 18 or 45
|
16
|
2 (1.7%)
|
0.6 (0.1-4.0)
|
All (n = 365)
|
HPV16 only
|
158
|
28 (7.7%)
|
1
|
|
HPV16 + 6 or 11
|
68
|
23 (6.3%)
|
2.4 (1.3-4.6)
|
|
HPV16 + 31 or 33
|
83
|
9 (2.5%)
|
0.6 (0.3-1.3)
|
|
HPV16 + 18 or 45
|
56
|
8 (2.2%)
|
0.8 (0.3-1.8)
|
- All = combined data of Finnish and Ugandan women
- Cutoff_30% = using low avidity controls mean plus 3 standard deviations